AstraZeneca Secures $287M Army Contract for COVID-19 Vaccine Delivery

AstraZeneca will supply 200 doses of the coronavirus vaccine candidate AZD1222 to the U.S. Army under a $286.9M firm-fixed-price contract.

The military branch received one bid for the procurement effort and obligated the full value of the award, the Department of Defense said Thursday.

Contract work will take place in Albuquerque, New Mexico, and West Chester Township, Ohio, through June 30, 2021.

The University of Oxford in England co-invented AZD1222 with Vaccitech, a biotechnology company that was spun out of the university's Jenner Institute.

AstraZeneca said Oct. 23 it resumed late-stage clinical trials of the experimental vaccine in the U.S.after the Food and Drug Administration completed a review of drug safety data.

Sponsor

Stay ahead in GovCon

Join thousands of government contractors who rely on GovCon Wire for the latest updates in federal spending, bid opportunities, and compliance changes.

Whether you’re new to the space or scaling up, our brief keeps you informed and ready to act.

I'm Interested In: